Results 171 to 180 of about 53,590 (235)

cellMCD Effectively Discovers Drug Resistance and Sensitivity Genes for Acute Myeloid Leukemia. [PDF]

Genes (Basel)
Obodo D, Nguyen NHK, Cao X, Parcha PK, Vulpe CD, Lamba JK, Pounds SB.   +6 more
europepmc   +1 more source

SRSF2 mutations drive daunorubicin resistance in acute myeloid leukemia via THBS1 stabilization. [PDF]

J Exp Clin Cancer Res
Ye W, Wu X, Tang Y, Zhang Y, Du Y, Yang K, Yang Y, Gong Y.   +7 more
europepmc   +1 more source

Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML. [PDF]

Blood Neoplasia
Jain J, Pugh K, Handa S, Dvorak-Kornaus KM, Zhao Q, Walter RB, Cook R, Saultz J, Swords R, Li J, Laszlo GS, Grieselhuber NR, Mims AS, Larkin KTM, Sahasrabudhe K, Blachly JS, Behbehani GK, Eisfeld AK, Long M, Srisuwananukorn A, Koenig KL, Borate U.   +21 more
europepmc   +1 more source

Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives. [PDF]

Oncol Res
Chen T, Kim G, Rahimi Y, Kamdar M, Fernandez-Hernandez E, Woan K, Tam EL, Yaghmour G.   +7 more
europepmc   +1 more source

Adult Acute Myeloid Leukaemia With <i>DDX3X::MLLT10</i>: A Rare Entity With Significant Unmet Clinical Needs. [PDF]

EJHaem
Ng JY, Sr A, Joshi M, Talaulikar D.
europepmc   +1 more source

Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia. [PDF]

Signal Transduct Target Ther
Gonzales F, Peyrouze P, Laurent D, Boyer T, Boukrout N, Couturier C, Houdiard S, Lisi V, Barthélémy A, Sevrin F, Plesa A, Bongiovanni A, Pottier N, Preudhomme C, Lavallée VP, Geles K, Duployez N, Berthon C, Roumier C, Cheok M.   +19 more
europepmc   +1 more source

Targeting enabled homolog with daunorubicin inhibits ERK1/2/c-Fos pathway and suppresses hepatocellular carcinoma progression. [PDF]

Clin Transl Med
Li ZM, Liu G, Liu QQ, You WM, Zhao MG.
europepmc   +1 more source

High-throughput drug screening in advanced pre-clinical 3D melanoma models identifies potential first-line therapies for NRAS-mutated melanoma. [PDF]

J Exp Clin Cancer Res
Angeli C, Philippidou D, Klein E, Margue C, Ghosh S, Maldonado MLC, Tiso N, Risato G, Irfan F, Santos B, Cutrona M, Wroblewska JP, Kreis S.   +12 more
europepmc   +1 more source

Development and evaluation of a novel capillary blood collection method for decentralized therapeutic drug monitoring using the True Dose kit. [PDF]

Sci Rep
Komninos N, De Chiara S, Checa A, Wiklander O, Rydberg P, Hedayati E.   +5 more
europepmc   +1 more source

Exploratory Research of Intraductal Chemotherapy to Control the Focal Breast Lesion of Breast Cancer. [PDF]

Breast Cancer (Dove Med Press)
Lin X, Li X, Wei Q, Yuan H, Zhong M, Qiao J, Gong J, Li Y.   +7 more
europepmc   +1 more source